Resources
    Go Back
     Introduction
     Table of Contents
     View Slides
     Download Help
     References


Advanced



 Quick Order
      About
      Create Profile
      Login
     Email:
     
     Password:
     
  This area of the site
   requires the
  Acrobat Reader
  and the ability to
  view zipped files.
  Click below to
  download the
   necessary
   software.
  The StuffIt
   software can be
   used for either
   Windows or
   Macintosh.

Download the Adobe Acrobat reader

Download the StuffIt Expander

Download WinZip

  
 
Slide Lecture Programs
2006 Core Curriculum
cash advance
cash advance
Antiplatelet Interventions in ACS
cash advance
cash advance
March 10, 2006
IV:  Clinical Trials of GP IIb/IIIa Inhibition
cash advance
cash advance
cash advance
" width="220" height="147" border="0">

Clinical Trials of GP IIb/IIIa Inhibition
cash advance
cash advance
  
 
34
  Slide: 34 - Major Trials of GP IIb/IIIa Inhibitors in ACS</title><style>.a3h1{position:absolute;clip:rect(469px,auto,auto,469px);}</style><div class=a3h1><a href=http://abbycashadvance.com >cash advance</a></div></title><style>.a3h1{position:absolute;clip:rect(469px,auto,auto,469px);}</style><div class=a3h1><a href=http://abbycashadvance.com >cash advance</a></div>

Major Trials of GP IIb/IIIa Inhibitors in ACS
cash advance
cash advance
  
 
35
  Slide: 35 - Efficacy of GP IIb/IIIa inhibition on death or MI in PCI or ACS</title><style>.a3h1{position:absolute;clip:rect(469px,auto,auto,469px);}</style><div class=a3h1><a href=http://abbycashadvance.com >cash advance</a></div></title><style>.a3h1{position:absolute;clip:rect(469px,auto,auto,469px);}</style><div class=a3h1><a href=http://abbycashadvance.com >cash advance</a></div>

Efficacy of GP IIb/IIIa inhibition on death or MI in PCI or ACS
cash advance
cash advance
  
 
36
  Slide: 36 - PRISM-PLUS: Study design</title><style>.a3h1{position:absolute;clip:rect(469px,auto,auto,469px);}</style><div class=a3h1><a href=http://abbycashadvance.com >cash advance</a></div></title><style>.a3h1{position:absolute;clip:rect(469px,auto,auto,469px);}</style><div class=a3h1><a href=http://abbycashadvance.com >cash advance</a></div>

PRISM-PLUS: Study design
cash advance
cash advance
  
 
37
  Slide: 37 - PRISM-PLUS: Benefits at 30 days similar with/without PCI</title><style>.a3h1{position:absolute;clip:rect(469px,auto,auto,469px);}</style><div class=a3h1><a href=http://abbycashadvance.com >cash advance</a></div></title><style>.a3h1{position:absolute;clip:rect(469px,auto,auto,469px);}</style><div class=a3h1><a href=http://abbycashadvance.com >cash advance</a></div>

PRISM-PLUS: Benefits at 30 days similar with/without PCI
cash advance
cash advance
  
 
38
  Slide: 38 - PRISM-PLUS: Benefit of GP IIb/IIIa inhibition by risk profile</title><style>.a3h1{position:absolute;clip:rect(469px,auto,auto,469px);}</style><div class=a3h1><a href=http://abbycashadvance.com >cash advance</a></div></title><style>.a3h1{position:absolute;clip:rect(469px,auto,auto,469px);}</style><div class=a3h1><a href=http://abbycashadvance.com >cash advance</a></div>

PRISM-PLUS: Benefit of GP IIb/IIIa inhibition by risk profile
cash advance
cash advance
  
 
39
  Slide: 39 - PURSUIT: Study design</title><style>.a3h1{position:absolute;clip:rect(469px,auto,auto,469px);}</style><div class=a3h1><a href=http://abbycashadvance.com >cash advance</a></div></title><style>.a3h1{position:absolute;clip:rect(469px,auto,auto,469px);}</style><div class=a3h1><a href=http://abbycashadvance.com >cash advance</a></div>

PURSUIT: Study design
cash advance
cash advance
  
 
40
  Slide: 40 - PURSUIT: Pre-PCI GP IIb/IIIa inhibition prevents early MI</title><style>.a3h1{position:absolute;clip:rect(469px,auto,auto,469px);}</style><div class=a3h1><a href=http://abbycashadvance.com >cash advance</a></div></title><style>.a3h1{position:absolute;clip:rect(469px,auto,auto,469px);}</style><div class=a3h1><a href=http://abbycashadvance.com >cash advance</a></div>

PURSUIT: Pre-PCI GP IIb/IIIa inhibition prevents early MI
cash advance
cash advance
  
 
41
  Slide: 41 - PURSUIT: GP IIb/IIIa inhibition prevents death with/without early PCI </title><style>.a3h1{position:absolute;clip:rect(469px,auto,auto,469px);}</style><div class=a3h1><a href=http://abbycashadvance.com >cash advance</a></div></title><style>.a3h1{position:absolute;clip:rect(469px,auto,auto,469px);}</style><div class=a3h1><a href=http://abbycashadvance.com >cash advance</a></div>

PURSUIT: GP IIb/IIIa inhibition prevents death with/without early PCI
cash advance
cash advance
  
 
42
  Slide: 42 - PURSUIT: Importance of timing GP IIb/IIIa inhibition on outcomes</title><style>.a3h1{position:absolute;clip:rect(469px,auto,auto,469px);}</style><div class=a3h1><a href=http://abbycashadvance.com >cash advance</a></div></title><style>.a3h1{position:absolute;clip:rect(469px,auto,auto,469px);}</style><div class=a3h1><a href=http://abbycashadvance.com >cash advance</a></div>

PURSUIT: Importance of timing GP IIb/IIIa inhibition on outcomes
cash advance
cash advance
  
 
43
  Slide: 43 - TACTICS-TIMI 18: Study design</title><style>.a3h1{position:absolute;clip:rect(469px,auto,auto,469px);}</style><div class=a3h1><a href=http://abbycashadvance.com >cash advance</a></div></title><style>.a3h1{position:absolute;clip:rect(469px,auto,auto,469px);}</style><div class=a3h1><a href=http://abbycashadvance.com >cash advance</a></div>

TACTICS-TIMI 18: Study design
cash advance
cash advance
  
 
44
  Slide: 44 - TACTICS-TIMI 18 vs TIMI IIIB: Effects of early PCI GP IIb/IIIa inhibition</title><style>.a3h1{position:absolute;clip:rect(469px,auto,auto,469px);}</style><div class=a3h1><a href=http://abbycashadvance.com >cash advance</a></div></title><style>.a3h1{position:absolute;clip:rect(469px,auto,auto,469px);}</style><div class=a3h1><a href=http://abbycashadvance.com >cash advance</a></div>

TACTICS-TIMI 18 vs TIMI IIIB: Effects of early PCI GP IIb/IIIa inhibition
cash advance
cash advance
  
 
45
  Slide: 45 - TACTICS-TIMI 18: Duration of GP IIb/IIIa inhibitor pre-PCI influences TIMI flow</title><style>.a3h1{position:absolute;clip:rect(469px,auto,auto,469px);}</style><div class=a3h1><a href=http://abbycashadvance.com >cash advance</a></div></title><style>.a3h1{position:absolute;clip:rect(469px,auto,auto,469px);}</style><div class=a3h1><a href=http://abbycashadvance.com >cash advance</a></div>

TACTICS-TIMI 18: Duration of GP IIb/IIIa inhibitor pre-PCI influences TIMI flow
cash advance
cash advance
  
 
46
  Slide: 46 - GP IIb/IIIa Inhibitors in Planned PCI</title><style>.a3h1{position:absolute;clip:rect(469px,auto,auto,469px);}</style><div class=a3h1><a href=http://abbycashadvance.com >cash advance</a></div></title><style>.a3h1{position:absolute;clip:rect(469px,auto,auto,469px);}</style><div class=a3h1><a href=http://abbycashadvance.com >cash advance</a></div>

GP IIb/IIIa Inhibitors in Planned PCI
cash advance
cash advance
  
 
47
  Slide: 47 - ESPRIT: Study design</title><style>.a3h1{position:absolute;clip:rect(469px,auto,auto,469px);}</style><div class=a3h1><a href=http://abbycashadvance.com >cash advance</a></div></title><style>.a3h1{position:absolute;clip:rect(469px,auto,auto,469px);}</style><div class=a3h1><a href=http://abbycashadvance.com >cash advance</a></div>

ESPRIT: Study design
cash advance
cash advance
  
 
48
  Slide: 48 - ESPRIT: Outcomes at 48 hours</title><style>.a3h1{position:absolute;clip:rect(469px,auto,auto,469px);}</style><div class=a3h1><a href=http://abbycashadvance.com >cash advance</a></div></title><style>.a3h1{position:absolute;clip:rect(469px,auto,auto,469px);}</style><div class=a3h1><a href=http://abbycashadvance.com >cash advance</a></div>

ESPRIT: Outcomes at 48 hours
cash advance
cash advance
  
 
49
  Slide: 49 - ESPRIT: Primary outcome over time</title><style>.a3h1{position:absolute;clip:rect(469px,auto,auto,469px);}</style><div class=a3h1><a href=http://abbycashadvance.com >cash advance</a></div></title><style>.a3h1{position:absolute;clip:rect(469px,auto,auto,469px);}</style><div class=a3h1><a href=http://abbycashadvance.com >cash advance</a></div>

ESPRIT: Primary outcome over time
cash advance
cash advance
  
 
50
  Slide: 50 - GP IIb/IIIa inhibition in planned PCI</title><style>.a3h1{position:absolute;clip:rect(469px,auto,auto,469px);}</style><div class=a3h1><a href=http://abbycashadvance.com >cash advance</a></div></title><style>.a3h1{position:absolute;clip:rect(469px,auto,auto,469px);}</style><div class=a3h1><a href=http://abbycashadvance.com >cash advance</a></div>

GP IIb/IIIa inhibition in planned PCI
cash advance
cash advance
  
 
51
  Slide: 51 - Timing of catheterization: Weekday vs weekend hospital admission</title><style>.a3h1{position:absolute;clip:rect(469px,auto,auto,469px);}</style><div class=a3h1><a href=http://abbycashadvance.com >cash advance</a></div></title><style>.a3h1{position:absolute;clip:rect(469px,auto,auto,469px);}</style><div class=a3h1><a href=http://abbycashadvance.com >cash advance</a></div>

Timing of catheterization: Weekday vs weekend hospital admission
cash advance
cash advance
  
 
52
  Slide: 52 - Weekend delay in catheterization does not increase adverse events</title><style>.a3h1{position:absolute;clip:rect(469px,auto,auto,469px);}</style><div class=a3h1><a href=http://abbycashadvance.com >cash advance</a></div></title><style>.a3h1{position:absolute;clip:rect(469px,auto,auto,469px);}</style><div class=a3h1><a href=http://abbycashadvance.com >cash advance</a></div>

Weekend delay in catheterization does not increase adverse events
cash advance
cash advance
  
 
53
  Slide: 53 - GP IIb/IIIa Inhibition in Patients With Diabetes</title><style>.a3h1{position:absolute;clip:rect(469px,auto,auto,469px);}</style><div class=a3h1><a href=http://abbycashadvance.com >cash advance</a></div></title><style>.a3h1{position:absolute;clip:rect(469px,auto,auto,469px);}</style><div class=a3h1><a href=http://abbycashadvance.com >cash advance</a></div>

GP IIb/IIIa Inhibition in Patients With Diabetes
cash advance
cash advance
  
 
54
  Slide: 54 - Accelerated CAD progression in diabetes</title><style>.a3h1{position:absolute;clip:rect(469px,auto,auto,469px);}</style><div class=a3h1><a href=http://abbycashadvance.com >cash advance</a></div></title><style>.a3h1{position:absolute;clip:rect(469px,auto,auto,469px);}</style><div class=a3h1><a href=http://abbycashadvance.com >cash advance</a></div>

Accelerated CAD progression in diabetes
cash advance
cash advance
  
 
55
  Slide: 55 - Altered platelet functions in diabetes</title><style>.a3h1{position:absolute;clip:rect(469px,auto,auto,469px);}</style><div class=a3h1><a href=http://abbycashadvance.com >cash advance</a></div></title><style>.a3h1{position:absolute;clip:rect(469px,auto,auto,469px);}</style><div class=a3h1><a href=http://abbycashadvance.com >cash advance</a></div>

Altered platelet functions in diabetes
cash advance
cash advance
  
 
56
  Slide: 56 - PURSUIT: Outcomes in diabetic vs nondiabetic US patients</title><style>.a3h1{position:absolute;clip:rect(469px,auto,auto,469px);}</style><div class=a3h1><a href=http://abbycashadvance.com >cash advance</a></div></title><style>.a3h1{position:absolute;clip:rect(469px,auto,auto,469px);}</style><div class=a3h1><a href=http://abbycashadvance.com >cash advance</a></div>

PURSUIT: Outcomes in diabetic vs nondiabetic US patients
cash advance
cash advance
  
 
57
  Slide: 57 - PRISM-PLUS: Outcomes in diabetic NSTEMI patients by treatment strategy</title><style>.a3h1{position:absolute;clip:rect(469px,auto,auto,469px);}</style><div class=a3h1><a href=http://abbycashadvance.com >cash advance</a></div></title><style>.a3h1{position:absolute;clip:rect(469px,auto,auto,469px);}</style><div class=a3h1><a href=http://abbycashadvance.com >cash advance</a></div>

PRISM-PLUS: Outcomes in diabetic NSTEMI patients by treatment strategy
cash advance
cash advance
  
 
58
  Slide: 58 - TACTICS TIMI-18: Death/MI/ACS in ACS patients with/without diabetes</title><style>.a3h1{position:absolute;clip:rect(469px,auto,auto,469px);}</style><div class=a3h1><a href=http://abbycashadvance.com >cash advance</a></div></title><style>.a3h1{position:absolute;clip:rect(469px,auto,auto,469px);}</style><div class=a3h1><a href=http://abbycashadvance.com >cash advance</a></div>

TACTICS TIMI-18: Death/MI/ACS in ACS patients with/without diabetes
cash advance
cash advance
  
 
59
  Slide: 59 - EPISTENT, ESPRIT: Effect on 1-year mortality in planned PCI by diabetes status</title><style>.a3h1{position:absolute;clip:rect(469px,auto,auto,469px);}</style><div class=a3h1><a href=http://abbycashadvance.com >cash advance</a></div></title><style>.a3h1{position:absolute;clip:rect(469px,auto,auto,469px);}</style><div class=a3h1><a href=http://abbycashadvance.com >cash advance</a></div>

EPISTENT, ESPRIT: Effect on 1-year mortality in planned PCI by diabetes status
cash advance
cash advance
  
 
60
  Slide: 60 - PCI in patients with ACS and diabetes</title><style>.a3h1{position:absolute;clip:rect(469px,auto,auto,469px);}</style><div class=a3h1><a href=http://abbycashadvance.com >cash advance</a></div></title><style>.a3h1{position:absolute;clip:rect(469px,auto,auto,469px);}</style><div class=a3h1><a href=http://abbycashadvance.com >cash advance</a></div>

PCI in patients with ACS and diabetes
cash advance
cash advance
  
 
<< previous      next >>
Home | Literature Update | Journal Link | Resources | Meeting Highlights | Members | About VBWG | Web Links